{"nct_id":"NCT01909453","title":"Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2013-09-12","start_date_type":"ACTUAL","primary_completion_date":"2016-11-09","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}